Clinical • P2 data • PD(L)-1 Biomarker • IO biomarker
|
HER-2 (Human epidermal growth factor receptor 2) • PD-L1 (Programmed death ligand 1) • TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • MYC (V-myc avian myelocytomatosis viral oncogene homolog) • KMT2D (Lysine Methyltransferase 2D) • MLL2 (Myeloid/lymphoid or mixed-lineage leukemia 2)
|
PD-L1 expression • HER-2 positive • TP53 mutation • HER-2 amplification • PIK3CA mutation • MYC amplification • HR negative • KMT2D mutation • MLL2 mutation • MLL mutation • TP53 amplification
|
Herceptin (trastuzumab) • Tecentriq (atezolizumab) • docetaxel • Perjeta (pertuzumab)